| 中文名称 |
Pemirolast potassium
|
| 中文别名 |
吡嘧司特钾;9-甲基-3-(1H-四氮唑-5-基)-4H-吡啶并[1,2a]嘧啶-4-酮钾;2 -[3-(甲氨基)-1-(2 - 噻吩基)丙基] -1-萘酚盐酸盐;4-(4-环己基苯基)-1,3-噻唑-2-胺;9-甲基-3-(1H-四唑-5-基)-4H-吡啶1,2-a嘧啶-4-酮钾盐;9-甲基-3-(1H-四唑-5-基)-4H-吡啶并[1,2-a]嘧啶-4-酮钾盐;Pemirolast Potassium Hydrate 吡嘧司特钾水合物;吡嘧司特钾标准品(JP);吡嘧司特钾水合物;毗嘧司特钾
|
| 英文名称 |
Pemirolast potassium
|
| 英文别名 |
Pemirolast Potassium;Pemirolast Potassium Hydrate;Pemirolast potassium salt;9-Methyl-3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one Potassium Salt Hydrate;BMY26517;BMY-26517;potassium,9-methyl-3-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)pyrido[1,2-a]pyrimidin-4-one;TWT8152;TWT-8152;9-Methyl-3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one Potassium Salt;10-Methyl-4-(2H-tetrazol-5-yl)-2,6-diazabicyclo[4.4.0]deca-1,3,7,9-tetraen-5-one potassium;BMY 26517;9-Methyl-3-(1H-tetrazol-5-yl)-4H-pyrido[1,2-a]pyrimidin-4-one potassium salt; BMY 26517;Pemirolast potassium
|
| Cas No. |
100299-08-9
|
| 分子式 |
C10H7N6O-.K+
|
| 分子量 |
266.30
|
| 包装储存 |
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
|
| 详情描述 |
Pemirolast (TWT-8152) 钾盐是H1组胺受体拮抗剂和肥大细胞稳定剂,可作为抗过敏化合物。
|
| 产品详情 |
Pemirolast (TWT-8152) 钾盐是H1组胺受体拮抗剂和肥大细胞稳定剂,可作为抗过敏化合物。
|
| 生物活性 |
Pemirolast potassium (TWT-8152) is a histamine H1 antagonist and mast cell stabilizer that acts as an antiallergic agent.
Target: Histamine H1 Receptor
Pemirolast potassium (TWT-8152) is a new oral, nonbronchodilator antiallergy medication that is being evaluated for the therapy of asthma [1].
Pemirolast potassium (TWT-8152) inhibits chemical mediator release from tissue mast cells and is also shown to inhibit the release of peptides including substance P, Pemirolast potassium (TWT-8152) reduces kaolin intake by inhibition of substance P release in rats [2].
Pemirolast potassium (TWT-8152) potently attenuates paclitaxel hypersensitivity reactions through inhibition of the release of sensory neuropeptides in rats [3].
Pemirolast potassium (TWT-8152) potassium is used for the treatment of allergic conjunctivitis and prophylaxis for pulmonary hypersensitivity reactions to drugs such as paclitaxel [4].
|
| 性状 |
Solid
|
| 运输条件 |
Room temperature in continental US; may vary elsewhere.
|
| 储存方式 |
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
|
| ClinicalTrial |
|
| 参考文献 |
[1]. Kemp, J.P., et al., Pemirolast, a new oral nonbronchodilator drug for chronic asthma. Ann Allergy, 1992. 68(6): p. 488-91.[2]. Tatsushima, Y., et al., Pemirolast reduces cisplatin-induced kaolin intake in rats. Eur J Pharmacol, 2011. 661(1-3): p. 57-62.[3]. Itoh, Y., et al., Pemirolast potently attenuates pac
|
| 溶解度数据 |
In Vitro: H2O : 50 mg/mL (187.76 mM; Need ultrasonic)配制储备液
|
[1]. Kemp, J.P., et al., Pemirolast, a new oral nonbronchodilator drug for chronic asthma. Ann Allergy, 1992. 68(6): p. 488-91.[2]. Tatsushima, Y., et al., Pemirolast reduces cisplatin-induced kaolin intake in rats. Eur J Pharmacol, 2011. 661(1-3): p. 57-62.[3]. Itoh, Y., et al., Pemirolast potently attenuates pac
1:一般建议:溶解度为Medlife测试数据,可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解,请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异,仅做参考,具体以实验方案为准。
2:储存条件:粉末-20°C一般情况可以保存3年,溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异,请细致阅读产品信息,并辅助参考相关文献描述。